Browse by:

Harvard Bio sees slight increase in revenue, earnings

Harvard Bioscience said a focus on its global growth strategy and a weaker dollar compared to the British pound and the Euro helped boost revenue slightly, as the life sciences manufacturer brought...

RXi initiates phase 2 study

Emily Micucci |

Marlborough-based RXi Pharmaceuticals, a clinical-stage biotechnology company, has initiated a third phase 2 study of its anti-scarring drug RXI-109.

Sevcon announces rights offering terms

Emily Micucci |

Sevcon Inc. of Southborough has announced the terms of its $10-million rights offering to shareholders. to acquire The Princeton Review

Emily Micucci |

Media and internet company IAC said it will acquire The Princeton Review, the Natick-based test preparation and college admission services company owned by Charlesbank Capital Partners.

Sales up, net income down at Psychemedics

Michael Novinson |

Revenues soared while profits sunk for Psychemedics Corp. of Acton in the second quarter of 2014.

Cognex reports record profits, revenue

Michael Novinson |

Natick-based Cognex Corp. announced record profits and revenues for its second quarter.

Humira fuels AbbVie sales and earnings

Global sales for Illinois-based drug firm AbbVie rose 5 percent in the second quarter, driven primarily by a 26-percent jump in sales for its arthritis drug Humira.

ViryaNet shareholders approve $18.8M sale

John Agoglia |

Stockholders for Westborough mobile software company ViryaNet have voted to approve the company's acquisition by Verisae Inc. for $18.8 million in cash announced last month.

Framingham drug maker to test pre-eclampsia med

John Agoglia |

rEVO Biologics of Framingham will begin the third testing phase of a drug intended to treat pre-eclampsia in pregnant women.

BSX profits plunge despite sales growth

John Agoglia |

Strong sales from several divisions, as well as international growth of 7 percent, were tarnished by heavy expenses as Boston Scientific Corp. (BSX) reported a 97-percent drop in profits in its...

Copyright 2014 New England Business Media